García-Bosch O - Search Results

1

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.

Rimola J, Rodriguez S, García-Bosch O, Ordás I, Ayala E, Aceituno M, Pellisé M, Ayuso C, Ricart E, Donoso L, Panés J. Rimola J, et al. Gut. 2009 Aug;58(8):1113-20. doi: 10.1136/gut.2008.167957. Epub 2009 Jan 9. Gut. 2009. PMID: 19136510 Free article.

2

Comparison of Diagnostic Accuracy and Impact of Magnetic Resonance Imaging and Colonoscopy for the Management of Crohn's Disease.

García-Bosch O, Ordás I, Aceituno M, Rodríguez S, Ramírez AM, Gallego M, Ricart E, Rimola J, Panes J. García-Bosch O, et al. J Crohns Colitis. 2016 Jun;10(6):663-9. doi: 10.1093/ecco-jcc/jjw015. Epub 2016 Jan 18. J Crohns Colitis. 2016. PMID: 26783346

3

Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease.

Rimola J, Rodríguez S, García-Bosch O, Ricart E, Pagès M, Pellisé M, Ayuso C, Panés J. Rimola J, et al. Radiographics. 2009 May-Jun;29(3):701-19. doi: 10.1148/rg.293085115. Radiographics. 2009. PMID: 19448111 Review.

4

Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.

Rimola J, Ordás I, Rodriguez S, García-Bosch O, Aceituno M, Llach J, Ayuso C, Ricart E, Panés J. Rimola J, et al. Inflamm Bowel Dis. 2011 Aug;17(8):1759-68. doi: 10.1002/ibd.21551. Epub 2010 Nov 8. Inflamm Bowel Dis. 2011. PMID: 21744431 Clinical Trial.

5

Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study.

Ordás I, Rimola J, García-Bosch O, Rodríguez S, Gallego M, Etchevers MJ, Pellisé M, Feu F, González-Suárez B, Ayuso C, Ricart E, Panés J. Ordás I, et al. Gut. 2013 Nov;62(11):1566-72. doi: 10.1136/gutjnl-2012-303240. Epub 2012 Aug 30. Gut. 2013. PMID: 22936673

6

Review article: stem cell therapies for inflammatory bowel disease - efficacy and safety.

García-Bosch O, Ricart E, Panés J. García-Bosch O, et al. Aliment Pharmacol Ther. 2010 Oct;32(8):939-52. doi: 10.1111/j.1365-2036.2010.04439.x. Epub 2010 Aug 19. Aliment Pharmacol Ther. 2010. PMID: 20804451 Free article. Review.

7

Are we giving biologics too late? The case for early versus late use.

Ricart E, García-Bosch O, Ordás I, Panés J. Ricart E, et al. World J Gastroenterol. 2008 Sep 28;14(36):5523-7. doi: 10.3748/wjg.14.5523. World J Gastroenterol. 2008. PMID: 18810770 Free PMC article. Review.

8

Long-Term Follow-Up of Patients Treated with Infliximab for Ulcerative Colitis: Predictive Factors of Response-An Observational Study.

García-Bosch O, Aceituno M, Ordás I, Etchevers J, Sans M, Feu F, Panés J, Ricart E. García-Bosch O, et al. Dig Dis Sci. 2016 Jul;61(7):2051-9. doi: 10.1007/s10620-016-4089-2. Epub 2016 Feb 26. Dig Dis Sci. 2016. PMID: 26921082

9

Risk factors and characteristics of extent progression in ulcerative colitis.

Etchevers MJ, Aceituno M, García-Bosch O, Ordás I, Sans M, Ricart E, Panés J. Etchevers MJ, et al. Inflamm Bowel Dis. 2009 Sep;15(9):1320-5. doi: 10.1002/ibd.20897. Inflamm Bowel Dis. 2009. PMID: 19235909

10

WITHDRAWN: Cell therapies for inflammatory bowel disease.

Panés J, García-Bosch O, Salas A, Benitez D. Panés J, et al. Curr Drug Deliv. 2011 Oct 21. Online ahead of print. Curr Drug Deliv. 2011. PMID: 22023203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters